Teaching
- Courses for students in medicine studies, stomatology, and speech therapy:
- Neurology and Neurosurgery (ARNR.01.036)
- Neurology (ARNR.01.024)
- Alzheimer Disease and Others Dementias (ARNR.01.022)
- Lectures on Selected Topics in Neurology and Neurosurgery (ARNR.00.017)
Research and publications
Involvement in EU projects
- 2021-2025 nEUROcare – an European initiative for capacity building to meet the challenges of caring for people with neurodegenerative disorders in Sri Lanka
- 2019-2022 Palliative care in Parkinson’s disease / PD-Pal: Horizon 2020 call, Better Health and care, economic growth and sustainable health systems‘ H2020-SC1-BHC-2018-2020
- 2012–2015 Parkinson’s disease: epidemiology, clinical and molecular markers: European Regional Development Fund 2.1001.11-0017
- 2003-2005- Patient education in Parkinson’s disease / EduPark: European Commission QLRT 2001-02674
- 2001-2004 Information, health and social needs of older, disabled people (Parkinson’s disease) and their carers / InfoPark: European Commission QLRT 2000-00303
- 17 trials (Site Principal Investigator)
Estonian Research Projects:
- 2020-2024 Peripheral Nervous system involvement in Parkinson’s Disease: Estonian Research Council, PPRG957
- 2021-2023 Robotic system to observe motions and assess functional condition of the patients with neurologic disorders. Estonian Research Council, EAG143
- 2016-2019 Biomarkers for diagnosis and progression of neurodegenerative diseases: Parkinson’s disease and amyotrophic lateral sclerosis, PUT 1239
- + 8 more projects
Supervised dissertation:
- 6 PhD degrees
- 23 MSc degrees
Dissertations under supervision:
8 PhD students
Publications total / last 5 years
- Total Number of publications: 431 (among them, during last 5 years – 127 publications):
- 131 articles in international peer reviewed journals
- 28 monographs or book chapters
- 35 other scientific articles
- 181 abstracts
- 56 other publications
- Citations: 2812
- H-index: 25
Selected recent publications
- Medijainen K, Pääsuke M, Lukmann A,Taba P.Structured guideline-based physiotherapy reduces difficulties in activities of daily living in Parkinson’s disease. 2022: 50(1): 47-56.
- Deuschl G, Antonini A, Costa J, Śmiłowska K, Berg D, Corvol JC, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K,Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E.European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson’s Disease: I. Invasive Therapies. Eur J Neurol. 2022 Sep;29(9):2580-2595.
- Valla E, Nõmm S, Taba P, Medijainen K, Toomela A. Tremor-related feature engineering for machine learning based Parkinson’s disease diagnostics. Biomedical signal processing and Control 2022; 75, 103551.
- Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, et al. Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (Courage-PD) Consortium.Dairy Intake and Parkinson’s disease: A Mendelian randomization study. Mov Disord 2022; 37: 857-864.
- Muldmaa M, Mencacci NE, Pittman A, Kadastik-Eerme L, Sikk K,Taba P, Hardy J, Kõks S. Community-based genetic study of Parkinson’s disease in Estonia. Acta Neurol Scand. 2021:143: 89-95.
- Kurvits L, Lättekivi F, Reimann E, Kadastik-Eerme L, Kasterpalu KM, Kõks S, Taba P, Planken A. Transcriptomic profiles in Parkinson’s disease. Experimental Biology and Medicine (Maywood) 2021;
- Meinders MJ, Gentile G, Schrag AE, Konitsiotis S, Eggers C, Taba P, Lorenzl S, Odin P, Rosqvist K, Chaudhuri KR, Antonini A, Bloem BR, Groot MM. Advance care planning and care coordination for people with Parkinson’s disease and their family caregivers – study protocol for a multicentre, randomized controlled trial. Front Neurol 2021; 12: 673893.
- Liu G, Peng J, Liao Z, Locascio JJ, Corvol JC, Zhu F, Dong X, Maple-Grødem J, Campbell MC, Elbaz A, Lesage S, Brice A, Mangone G, Growdon JH, Hung AY, Schwarzschild MA, Hayes MT, Wills AM, Herrington TM, Ravina B, Shoulson I,Taba P, et al.Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease. Nat Genet 2021; 53: 787-793.
- Ennok M, Sikk K, Haldre S, Taba P. Cognitive profile of patients with manganese-methcathinone encephalopathy. Neurotoxicology 2020; 176: 138-143.
- Asser A, Hikima A, Raki M, Bergström K, Rose S, Juurmaa J, Krispin V, Muldmaa M, Lilles S, Rätsep H, Jenner P, Kõks S, Männistö PT, Taba P. Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusers. J Neural Transm (Vienna) 2020: 127: 717-714.
- Kadastik-Eerme L, Taba N, Asser T,Taba P. Incidence and Mortality of Parkinson’s Disease in Estonia. Neuroepidemiology 2019; 53(1-2):63-72.
- Billingsley JB, Lattekivi F, Planken A, Reimann E, Kurvits L, Kadastik-Eerme L, Kasterpalu KM, Bubb VJ, Quinn JP, Kõks S, Taba P. Analysis of repetitive element expression in the blood and skin of patients with Parkinson’s disease identifies differential expression of satellite elements. Scientific Reports 2019; 9: 4369.
- Nursi A, Padrik M, Nursi L, Pähkel M, Virkunen L, Küttim-Rips A, Taba P. Adaption and validation of the Mississippi Aphasia Screening Test to Estonian speakers with aphasia. Brain Behav 2019; 9: e01188.
- Galli E, Planken A, Kadastik-Eerme L, Saarma M,Taba P, Lindholm P. Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson’s Disease. Front Neurosci 2019;13:929.
Awards, grants
-
- 2013 Tartu University Honour Sign
- 2011 Medal of the Medical Faculty of the University of Tartu
- 1984 Prize of the Students’ Scientific Society in Neurology